Clinical Trials Core

$372,262P50FY2016CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Linked publications & trials

Paper 39702422 Paper 39567747 Paper 39546575 Paper 39478111 Paper 39048900 Paper 38947074 Paper 38885312 Paper 38766070 Paper 38709925 Paper 38622115 Paper 38615489 Paper 38458201 Paper 38260436 Paper 38190580 Paper 38167908 Paper 38100350 Paper 38011567 Paper 37980405 Paper 37900827 Paper 37676980 Paper 37399356 Paper 37141550 Paper 37076617 Paper 36951169 Paper 36914658 Paper 36889065 Paper 36817465 Paper 36619972 Paper 36609487 Paper 36463275 Paper 36441774 Paper 36409824 Paper 36352222 Paper 36325581 Paper 36268097 Paper 36223740 Paper 36074155 Paper 36068244 Paper 36048535 Paper 35923923 Paper 35797509 Paper 35766387 Paper 35658506 Paper 35641483 Paper 35617956 Paper 35482127 Paper 35447074 Paper 35446942 Paper 35363308 Paper 35304604 Paper 35304445 Paper 35292783 Paper 35248122 Paper 35149538 Paper 35110417 Paper 35025636 Paper 34853355 Paper 34607954 Paper 34508104 Paper 34388391 Paper 34353349 Paper 34179826 Paper 33997789 Paper 33976133 Paper 33941591 Paper 33891890 Paper 33738458 Paper 33385331 Paper 33293374 Paper 33257427 Paper 33256808 Paper 33138866 Paper 32997991 Paper 32975478 Paper 32939016 Paper 32704543 Paper 32601199 Paper 32576627 Paper 32571778 Paper 32546544 Paper 32416067 Paper 32393766 Paper 32277005 Paper 32249764 Paper 32245699 Paper 32170028 Paper 32067680 Paper 32019858 Paper 31670078 Paper 31462705 Paper 31409614 Paper 31263220 Paper 31061067 Paper 31015319 Paper 30988298 Paper 30962322 Paper 30956894 Paper 30840889 Paper 30795773 Paper 30692147

Abstract

The Clinical Trials Core will support all investigators in the Dana-Farber/Harvard SPORE in Breast Cancer conducting clinical trials. The Clinical Trials Core will coordinate preparation, review and activation of clinical studies developed within the SPORE and Inter-SPORE programs. Additionally, the Clinical Trials Core will facilitate recruitment and consent of patients, clinical management and follow-up of patients, data collection and management and real-time monitoring of accrual and toxicity once trials are open. The Core will work closely with other SPORE Cores to coordinate all aspects of clinical research, including biostatistics support and biospecimen collection. The Core will utilize the Dana-Farber/Harvard Cancer Center data management infrastructure to facilitate the multi-center trials. The Core has resources available to achieve the aims outlined in the proposal, including dedicated Co-Directors, institutional commitment of clinical research coordinators and research nurses from all the institutions participating in clinical trials in the SPORE.

View original record on NIH RePORTER →